Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Nichi-Iko Pharmaceutical Co Ltd
EPS (Diluted)
Nichi-Iko Pharmaceutical Co Ltd
EPS (Diluted) Peer Comparison
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
N
|
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
|
EPS (Diluted)
-¥1.6k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
EPS (Diluted)
¥92
|
CAGR 3-Years
-27%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-4%
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
EPS (Diluted)
¥104
|
CAGR 3-Years
39%
|
CAGR 5-Years
17%
|
CAGR 10-Years
2%
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
EPS (Diluted)
¥253
|
CAGR 3-Years
-4%
|
CAGR 5-Years
12%
|
CAGR 10-Years
-1%
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
EPS (Diluted)
¥198
|
CAGR 3-Years
16%
|
CAGR 5-Years
27%
|
CAGR 10-Years
6%
|
|
Astellas Pharma Inc
TSE:4503
|
EPS (Diluted)
¥9
|
CAGR 3-Years
-47%
|
CAGR 5-Years
-39%
|
CAGR 10-Years
-14%
|
See Also
What is Nichi-Iko Pharmaceutical Co Ltd's EPS (Diluted)?
EPS (Diluted)
-1.6k
JPY
Based on the financial report for Mar 31, 2022, Nichi-Iko Pharmaceutical Co Ltd's EPS (Diluted) amounts to -1.6k JPY.
What is Nichi-Iko Pharmaceutical Co Ltd's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 1Y
-2 281%
Over the last year, the EPS (Diluted) growth was -2 281%.